fingolimod hydrochloride has been researched along with Mycoses in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harirchian, MH; Kamali, H; Poursadeghfard, M; Sadeghipour, A; Sarraf, P | 1 |
| Correale, J | 1 |
2 other study(ies) available for fingolimod hydrochloride and Mycoses
| Article | Year |
|---|---|
Necrotizing fungal osteomyelitis and fingolimod, 4 years after treatment with fingolimod.
Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Multiple Sclerosis, Relapsing-Remitting; Mycoses; Necrosis; Opportunistic Infections; Osteomyelitis | 2020 |
New fungal infections associated with disease-modifying treatments in MS.
Topics: Dimethyl Fumarate; Fingolimod Hydrochloride; Humans; Mycoses; Natalizumab; Tinea | 2018 |